<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="{font-family : courier ; font-style : italic;} Ocul SurfOcul SurfThe" exact="Ocular" post="Surface1542-01241937-5913Elsevier Inc. pmcid: 7241406S1542-0124(20)30089-6 doi: 10.1016/j.jtos.2020.05.011 : Article The"/>
 <result pre="The eye as the discrete but defensible portal of coronavirus" exact="infection" post="CoroneoMinas Theodorem.coroneo@unsw.edu.auabâˆ—[a], [b], âˆ—Department of Ophthalmology, Prince of Wales"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="success by SARS-CoV-2, a highly contagious, potentially lethal, virus with" exact="ocular" post="tropism. Respiratory infection transmission via the eye and lacrimal-nasal"/>
 <result pre="SARS-CoV-2, a highly contagious, potentially lethal, virus with ocular tropism." exact="Respiratory" post="infection transmission via the eye and lacrimal-nasal pathway elucidated"/>
 <result pre="a highly contagious, potentially lethal, virus with ocular tropism. Respiratory" exact="infection" post="transmission via the eye and lacrimal-nasal pathway elucidated during"/>
 <result pre="adnexae represent a large surface area directly exposed to airborne" exact="viral" post="particles and hand contact. The virus may bind to"/>
 <result pre="the lungs and gut. Adenoviruses and influenza viruses share this" exact="ocular" post="tropism and despite differing ocular and systemic manifestations and"/>
 <result pre="and influenza viruses share this ocular tropism and despite differing" exact="ocular" post="and systemic manifestations and disease patterns, common lessons, particularly"/>
 <result pre="viruses share this ocular tropism and despite differing ocular and" exact="systemic" post="manifestations and disease patterns, common lessons, particularly in management,"/>
 <result pre="ocular tropism and despite differing ocular and systemic manifestations and" exact="disease" post="patterns, common lessons, particularly in management, emerge. Slit lamp"/>
 <result pre="usage places ophthalmologists at particular risk of exposure to high" exact="viral" post="loads (and poor prognosis) and as for adenoviral epidemics,"/>
 <result pre="as for adenoviral epidemics, this may be a setting for" exact="disease" post="transmission. Local, rather than systemic treatments blocking virus binding"/>
 <result pre="may be a setting for disease transmission. Local, rather than" exact="systemic" post="treatments blocking virus binding in this pathway (advocated for"/>
 <result pre="eye drops or aerosols containing drugs which appear efficacious via" exact="systemic" post="administration. A combination such as hydroxychloroquine, azithromycin and zinc,"/>
 <result pre="â€&quot; a pathway for transmission and treatment. â€¢Virus may bind" exact="ocular" post="surface ACE2 receptors &amp;amp; the lipophilic superficial tear film."/>
 <result pre="lungs and gut. â€¢Local hydroxychloroquine, azithromycin and zinc could block" exact="viral" post="binding. â€¢This may offer a safe, cost-effective and resource-sparing"/>
 <result pre="may be playing a central role in the current Coronavirus" exact="Disease" post="2019 (COVID-19) epidemic. The harbinger of the third zoonotic"/>
 <result pre="[1], was Dr Li Wenliang, an ophthalmologist, who died following" exact="infection" post="with COVID-19 [2,3]. It was thought he was infected"/>
 <result pre="was infected during examination of a patient with angle closure" exact="glaucoma" post="in the second week of January 2020. He suspected"/>
 <result pre="world history. The second instructive case is that of the" exact="respiratory" post="physician Guangfa Wang [4]. Days before pneumonia onset, his"/>
 <result pre="that of the respiratory physician Guangfa Wang [4]. Days before" exact="pneumonia" post="onset, his earliest symptoms related to left conjunctivitis, then"/>
 <result pre="from older studies tracing the passage of bacteria through the" exact="lacrimal" post="drainage system [5]. While an N95 respirator was worn,"/>
 <result pre="[5]. While an N95 respirator was worn, offering protection from" exact="infection" post="via oro-nasal pathways, eye protection was not. Evidence that"/>
 <result pre="infection via oro-nasal pathways, eye protection was not. Evidence that" exact="ocular" post="and periocular tissue may be uniquely placed as an"/>
 <result pre="tissue may be uniquely placed as an entry point for" exact="viral" post="invasion will be reviewed. At the height of the"/>
 <result pre="world influenza epidemic, a landmark paper appeared, proposing transmission of" exact="acute" post="respiratory infections via the eye and lacrimal-nasal pathway [5]"/>
 <result pre="influenza epidemic, a landmark paper appeared, proposing transmission of acute" exact="respiratory" post="infections via the eye and lacrimal-nasal pathway [5] (Fig."/>
 <result pre="epidemic, a landmark paper appeared, proposing transmission of acute respiratory" exact="infections" post="via the eye and lacrimal-nasal pathway [5] (Fig. 1"/>
 <result pre="lacrimatory-nasal mechanism for the mechanical disposition of organisms entering the" exact="upper" post="respiratory tract [5]. A third factor in this perfect"/>
 <result pre="mechanism for the mechanical disposition of organisms entering the upper" exact="respiratory" post="tract [5]. A third factor in this perfect storm"/>
 <result pre="perfect storm is the well-established but not well recognized coronavirus" exact="ocular" post="tropism [6]. The study of oculotropic influenza and adenoviruses"/>
 <result pre="oculotropic influenza and adenoviruses [[7], [8], [9]] sets precedents for" exact="disease" post="patterns, bought into focus by coronaviruses. Whereas influenza viruses"/>
 <result pre="into focus by coronaviruses. Whereas influenza viruses generally represent a" exact="respiratory" post="pathogen and only occasionally cause ocular complications, adenoviruses mirror"/>
 <result pre="viruses generally represent a respiratory pathogen and only occasionally cause" exact="ocular" post="complications, adenoviruses mirror image this disease pattern, causing severe"/>
 <result pre="and only occasionally cause ocular complications, adenoviruses mirror image this" exact="disease" post="pattern, causing severe ocular surface disease, and are often"/>
 <result pre="ocular complications, adenoviruses mirror image this disease pattern, causing severe" exact="ocular" post="surface disease, and are often highly contagious (known as"/>
 <result pre="(known as â€œeye hospital eye [10]) with fewer, seldom lethal," exact="systemic" post="manifestations. Thus, all three virus types share a common"/>
 <result pre="systemic manifestations. Thus, all three virus types share a common" exact="ocular" post="entrÃ©e but vary in their degree of contagion, ocular"/>
 <result pre="common ocular entrÃ©e but vary in their degree of contagion," exact="ocular" post="versus respiratory/system impact and lethality. Taken as a whole,"/>
 <result pre="versus respiratory/system impact and lethality. Taken as a whole, these" exact="disease" post="patterns have implications for more effective management strategies. Why"/>
 <result pre="of COVID-19? Dr Li Wenliang's death and the apparent high" exact="infection" post="rate in ophthalmologists (and ENT surgeons) [11], attributed to"/>
 <result pre="in ophthalmologists (and ENT surgeons) [11], attributed to the high" exact="viral" post="shedding from the nasal cavity, should not be unexpected."/>
 <result pre="the nasal cavity, should not be unexpected. A high initial" exact="viral" post="load is associated with poor prognosis [12] and ophthalmologists"/>
 <result pre="is also used to carry out surgical procedures. The back" exact="focal" post="distance (the distance of the subject from the front"/>
 <result pre="of ~28â€&quot;30Â cm. This proximity and the possibility of cross" exact="infection" post="between examiner and examinee has long been recognized and"/>
 <result pre="Of interest is that exhalation flow may stratify in a" exact="horizontal" post="layer at breathing zone height under certain conditions. Thus,"/>
 <result pre="lamp examination indicating distances between patient and physician: (a) Back" exact="focal" post="distance - 11Â cm, (b) Distance between front lens"/>
 <result pre="slit lamps and their accessory lenses are a source of" exact="infection" post="transmission has long been known [15]. In epidemic adenoviral"/>
 <result pre="of infection transmission has long been known [15]. In epidemic" exact="adenoviral keratoconjunctivitis" post="((AKC), shipyard/eye hospital eye) [10,16], ophthalmologists are not infrequently"/>
 <result pre="infection transmission has long been known [15]. In epidemic adenoviral" exact="keratoconjunctivitis" post="((AKC), shipyard/eye hospital eye) [10,16], ophthalmologists are not infrequently"/>
 <result pre="it does not usually result in death. The earlier severe" exact="acute" post="respiratory syndrome (SARS) epidemic resulted in recommendations for how"/>
 <result pre="does not usually result in death. The earlier severe acute" exact="respiratory" post="syndrome (SARS) epidemic resulted in recommendations for how to"/>
 <result pre="not usually result in death. The earlier severe acute respiratory" exact="syndrome" post="(SARS) epidemic resulted in recommendations for how to manage"/>
 <result pre="optimal method of transferring material in breaths between two individuals," exact="short" post="of actual facial contact. A very recent study provides"/>
 <result pre="is highly likely, since the virus can remain viable and" exact="infectious" post="in aerosols for hours and on different surfaces up"/>
 <result pre="of coronaviruses occurs via an airborne route [24], because infected," exact="symptomatic" post="patients tend to develop severe lower, as opposed to"/>
 <result pre="symptomatic patients tend to develop severe lower, as opposed to" exact="upper" post="respiratory tract infections, it has been supposed that airborne"/>
 <result pre="patients tend to develop severe lower, as opposed to upper" exact="respiratory" post="tract infections, it has been supposed that airborne agent"/>
 <result pre="has to be small enough to penetrate directly into the" exact="lower" post="respiratory tract to preferentially replicate there before causing disease."/>
 <result pre="to be small enough to penetrate directly into the lower" exact="respiratory" post="tract to preferentially replicate there before causing disease. That"/>
 <result pre="occur via the ocular-nasolacrimal pathway was not considered. Is the" exact="ocular" post="surface an entry point for SAR-CoV2? Human eyes are"/>
 <result pre="1919 study [5], a number of other studies have investigated" exact="ocular" post="surface area and reported as a total (for two"/>
 <result pre="studies have investigated ocular surface area and reported as a" exact="total" post="(for two eyes) as 226â€&quot;426 [25] and 300â€&quot;640Â mm2"/>
 <result pre="was a good estimate (Table 1 ) of the â€œvisibleâ€�" exact="ocular" post="surface. The later study [26] also explains variability in"/>
 <result pre="palpebral aperture is dependent on eye gaze direction. However, the" exact="total" post="ocular surface area has been estimated at ~1600â€&quot;1869 sq."/>
 <result pre="aperture is dependent on eye gaze direction. However, the total" exact="ocular" post="surface area has been estimated at ~1600â€&quot;1869 sq. mm/eye"/>
 <result pre="this consideration underestimates the potential ocular/periocular landing zone for a" exact="viral" post="particle. It is not an uncommon observation that makeup,"/>
 <result pre="that makeup, applied around the eye, can â€œmigrateâ€� onto the" exact="ocular" post="surface [29], similar to the phenomenon by which noxious"/>
 <result pre="eye. This may be due to subtle actions of Riolan's" exact="muscle" post="[30]. In fact, this mechanism of transport of agents"/>
 <result pre="been developed as an efficient delivery system for management of" exact="dry eye syndrome" post="[31]. This supracutaneous mechanism, might provide a substantial periocular"/>
 <result pre="as an efficient delivery system for management of dry eye" exact="syndrome" post="[31]. This supracutaneous mechanism, might provide a substantial periocular"/>
 <result pre="supracutaneous mechanism, might provide a substantial periocular area in which" exact="viral" post="particles could land and be â€œfunnelledâ€� onto the ocular"/>
 <result pre="which viral particles could land and be â€œfunnelledâ€� onto the" exact="ocular" post="surface and beyond. Table 1 provides available information on"/>
 <result pre="of the brow to be ~3000Â mm2, so that in" exact="total" post="with the ocular surface area, a landing site of"/>
 <result pre="to be ~3000Â mm2, so that in total with the" exact="ocular" post="surface area, a landing site of ~10,000Â mm2 would"/>
 <result pre="been made. Eyelash aerodynamics may also play a role [34]." exact="Eyelashes" post="have been shown to divert airflows, acting as a"/>
 <result pre="have been shown to divert airflows, acting as a passive" exact="ocular" post="dust controlling system. They reduce evaporation and particle deposition"/>
 <result pre="to 50%. In a comparative study [35], Asian eyelashes had" exact="lower" post="lift-up and curl-up angles, fewer numbers and a thicker"/>
 <result pre="in influencing the rate at which particles land on the" exact="ocular" post="surface is unknown. However, it is possible that a"/>
 <result pre="ocular surface is unknown. However, it is possible that a" exact="deficiency" post="in this mechanism could increase the risk of infection."/>
 <result pre="spray to that of the mouth and nares: (a), average" exact="total" post="eye surface exposed; shaded area represents proportion of time"/>
 <result pre="proportion of time not exposed, due to winking; (b), average" exact="total" post="mouth area exposed in talking; shaded area represents proportion"/>
 <result pre="proportion of time not exposed, due to closure; (c), average" exact="total" post="area of cross-section of nares exposed; shaded area represents"/>
 <result pre="owing to protected position and expiration [5]. Table 1 External" exact="ocular" post="surface areas. Table 1 Palpebral Aperture mm2 Methodology Reference"/>
 <result pre="226â€&quot;426 Digitized video images [25] 300â€&quot;640 Digitized video images [26]" exact="Total" post="Ocular Surface Area 3200 Designed instrument [27] 3738 Molds"/>
 <result pre="Digitized video images [25] 300â€&quot;640 Digitized video images [26] Total" exact="Ocular" post="Surface Area 3200 Designed instrument [27] 3738 Molds of"/>
 <result pre="3200 Designed instrument [27] 3738 Molds of cadaver eyes [38]" exact="Total" post="Orbital Aperture Area 2509 (estim) CT Scan [32] 1793â€&quot;1987"/>
 <result pre="Designed instrument [27] 3738 Molds of cadaver eyes [38] Total" exact="Orbital" post="Aperture Area 2509 (estim) CT Scan [32] 1793â€&quot;1987 Radiographs"/>
 <result pre="study [5], Bacillus prodigiosus (Serratia marcescens) was instilled into the" exact="lacrimal" post="sac of 5 volunteers and subsequently was recoverable from"/>
 <result pre="and 24Â h respectively. It was concluded that via this" exact="ocular" post="lacrimatory-nasal mechanism (Fig. 1, Fig. 2a, Fig. 2b, Fig."/>
 <result pre="1, Fig. 2a, Fig. 2b, Fig. 2c, Fig. 2d), the" exact="upper" post="respiratory tract of a person wearing a properly constructed"/>
 <result pre="Fig. 2a, Fig. 2b, Fig. 2c, Fig. 2d), the upper" exact="respiratory" post="tract of a person wearing a properly constructed mask"/>
 <result pre="exposing the eye briefly to direct droplet spray. Role of" exact="Ocular" post="Surface Cellular Receptors Identification of ocular surface cellular receptors"/>
 <result pre="droplet spray. Role of Ocular Surface Cellular Receptors Identification of" exact="ocular" post="surface cellular receptors utilized by respiratory viruses has provided"/>
 <result pre="Cellular Receptors Identification of ocular surface cellular receptors utilized by" exact="respiratory" post="viruses has provided information as to the permissiveness of"/>
 <result pre="respiratory viruses has provided information as to the permissiveness of" exact="ocular" post="tissue to infection with these agents [6,36]. Central to"/>
 <result pre="provided information as to the permissiveness of ocular tissue to" exact="infection" post="with these agents [6,36]. Central to COVID-19 pathogenicity is"/>
 <result pre="permissiveness of ocular tissue to infection with these agents [6,36]." exact="Central" post="to COVID-19 pathogenicity is that cellular entry is via"/>
 <result pre="surface expression of ACE2 protein was described in lung alveolar" exact="epithelial" post="cells and small intestinal enterocytes [42] and it was"/>
 <result pre="Of particular interest was the localisation of ACE to the" exact="epithelial" post="cells of both the cornea and conjunctiva. Apical epithelia"/>
 <result pre="ACE2 is the major determinant of SARS-CoV replication rate and" exact="disease" post="severity and that viral entry also depends on protease"/>
 <result pre="determinant of SARS-CoV replication rate and disease severity and that" exact="viral" post="entry also depends on protease activity, ACE2, rather than"/>
 <result pre="than protease activity, may be a limiting factor for initial" exact="viral" post="entry. This study confirmed evidence of ACE2 in the"/>
 <result pre="be some priority for re-evaluation of these elements in the" exact="ocular" post="surface [46]. The density of SARS-CoV-2 entry factors and"/>
 <result pre="SARS-CoV-2 entry factors and their presence or absence in the" exact="lacrimal" post="drainage system would be of interest, since viral particles"/>
 <result pre="in the lacrimal drainage system would be of interest, since" exact="viral" post="particles that land in the tear film need not"/>
 <result pre="in the tear film need not necessarily bind to an" exact="epithelial" post="cell immediately but could be presented with a second"/>
 <result pre="with a second opportunity (a â€œwash throughâ€� effect) in the" exact="lacrimal" post="drainage system. Tear film resilience may well protect the"/>
 <result pre="well protect the underlying corneal and conjunctival epithelium so that" exact="viral" post="adherence to the tear film could prevent access to"/>
 <result pre="to the tear film could prevent access to the apical" exact="epithelial" post="surface, which may account for the relatively low incidence"/>
 <result pre="in how coronaviruses and perhaps other enveloped viruses access the" exact="ocular" post="surface. In the skin, extracellular surface lipids provide a"/>
 <result pre="and while a similar function might keep viruses from accessing" exact="ocular" post="surface receptors, tear and supracutaneous flow could result in"/>
 <result pre="for the virus to bind to receptors downstream in the" exact="lacrimal" post="drainage pathway and beyond. The tear film, comprised of"/>
 <result pre="envelope [53] may be well suited to adhering to the" exact="ocular" post="surface. Coronavirus cell entry and adhesion require lipid rafts"/>
 <result pre="lipid layer [56] might act as â€œlipid raftâ€�, facilitating initial" exact="viral" post="adhesion. The precise nature of potential viral adhesion to"/>
 <result pre="raftâ€�, facilitating initial viral adhesion. The precise nature of potential" exact="viral" post="adhesion to the tear film requires elucidation since this"/>
 <result pre="represents another potential means of intervention via local rather than" exact="systemic" post="means. The possibility of ocular surface viral replication and"/>
 <result pre="intervention via local rather than systemic means. The possibility of" exact="ocular" post="surface viral replication and transmission should be further explored"/>
 <result pre="local rather than systemic means. The possibility of ocular surface" exact="viral" post="replication and transmission should be further explored given the"/>
 <result pre="finding of likely sustained SARS-CoV-2 replication in three patients with" exact="systemic" post="infection and conjunctivitis [[57], [58], [59]]. While it was"/>
 <result pre="of likely sustained SARS-CoV-2 replication in three patients with systemic" exact="infection" post="and conjunctivitis [[57], [58], [59]]. While it was found"/>
 <result pre="sustained SARS-CoV-2 replication in three patients with systemic infection and" exact="conjunctivitis" post="[[57], [58], [59]]. While it was found that no"/>
 <result pre="conjunctivitis [[57], [58], [59]]. While it was found that no" exact="viral" post="RNA was detected in the tear fluid and conjunctival"/>
 <result pre="the tear fluid and conjunctival secretions of infected patients without" exact="conjunctivitis" post="in one study, it was felt that this did"/>
 <result pre="with the concept that the tear film may protect the" exact="ocular" post="surface from epithelial infection and convey virus downstream. The"/>
 <result pre="that the tear film may protect the ocular surface from" exact="epithelial" post="infection and convey virus downstream. The nasolacrimal system, via"/>
 <result pre="the tear film may protect the ocular surface from epithelial" exact="infection" post="and convey virus downstream. The nasolacrimal system, via the"/>
 <result pre="downstream. The nasolacrimal system, via the nasopharynx (considered crucial for" exact="viral" post="replication [46]) thus provides a bridge between ocular and"/>
 <result pre="crucial for viral replication [46]) thus provides a bridge between" exact="ocular" post="and respiratory tissues, serving as a conduit for virus-containing"/>
 <result pre="viral replication [46]) thus provides a bridge between ocular and" exact="respiratory" post="tissues, serving as a conduit for virus-containing fluid exchange"/>
 <result pre="these systems is likely contributing to the tissue tropism of" exact="respiratory" post="viruses [60]. Furthermore, there is respiratory-ocular mucosal immune interdependence"/>
 <result pre="via the nasolacrimal lymphoid tissue [6,61]. Despite early suggestions of" exact="ocular" post="involvement [62] in this process, it appears that this"/>
 <result pre="in framing early guidelines for protection against infection. More recently," exact="American" post="Academy of Ophthalmology recommendations include protection for the mouth,"/>
 <result pre="potentially infected with this virus [63]. Thus, the pathophysiology of" exact="ocular" post="surface-SARS-CoV-2 interactions requires re-evaluation, not only to determine the"/>
 <result pre="interactions requires re-evaluation, not only to determine the dynamics of" exact="ocular" post="surface viral exposure and binding but also transmission via"/>
 <result pre="re-evaluation, not only to determine the dynamics of ocular surface" exact="viral" post="exposure and binding but also transmission via the lacrimal"/>
 <result pre="surface viral exposure and binding but also transmission via the" exact="lacrimal" post="drainage system. Less pathogenic coronaviruses as well as other"/>
 <result pre="lacrimal drainage system. Less pathogenic coronaviruses as well as other" exact="respiratory" post="viruses could be used in animal models to better"/>
 <result pre="elucidate this relatively unexplored pathway. Potential for intervention Thus, the" exact="ocular" post="surface, representing a large surface area, exposed to and"/>
 <result pre="in directly targeting the ACE2 receptor in this way are" exact="limited" post="[64]. Potentially, blocking the ACE2 receptor would deprive coronaviruses"/>
 <result pre="using antibodies [66] - anti-ACE2 but not anti-ACE1 antibody blocked" exact="viral" post="replication in a model system. Blocking of TMPRSS2 protease"/>
 <result pre="appears that ACE2, rather than protease activity, may be the" exact="viral" post="entry rate limiting factor [45]. Possible drug interventions targeting"/>
 <result pre="chloroquine. ACE inhibitors are widely used in the treatment of" exact="systemic" post="diseases including hypertension and are generally well tolerated [67]."/>
 <result pre="are widely used in the treatment of systemic diseases including" exact="hypertension" post="and are generally well tolerated [67]. This class of"/>
 <result pre="binding and catalysis and could prove to be unfavourable for" exact="viral" post="binding to the receptor and/or syncytial formation [69]. It"/>
 <result pre="inhibitors such as MLN-4760 may prove useful for prevention of" exact="viral" post="binding to ACE2 [70]. A search of FDA-approved drug"/>
 <result pre="(for that agent or a related compound) for previous topical" exact="ocular" post="surface usage. It is apparent that while for each"/>
 <result pre="concern in that there are precedents for paradoxical untoward drug" exact="systemic" post="effects that result in increased disease severity when in"/>
 <result pre="for paradoxical untoward drug systemic effects that result in increased" exact="disease" post="severity when in vitro testing alone might suggest efficacy"/>
 <result pre="might suggest efficacy [85]. Table 2 Proposed Agents For Initial" exact="Ocular" post="Surface anti-SARS-CoV-2 Intervention. Table 2 Proposed Agents For Initial"/>
 <result pre="Ocular Surface anti-SARS-CoV-2 Intervention. Table 2 Proposed Agents For Initial" exact="Ocular" post="Surface anti-SARS-CoV-2 Intervention Agent Anti- SARS-CoV-2 Effect Ocular Surface"/>
 <result pre="For Initial Ocular Surface anti-SARS-CoV-2 Intervention Agent Anti- SARS-CoV-2 Effect" exact="Ocular" post="Surface Application (for SARS-CoV-2-unrelated disease) In Vivo In Vitro"/>
 <result pre="SARS-CoV. Chloroquine has long been used in the treatment of" exact="malaria" post="and subsequently, autoimmune disorders (such as rheumatoid arthritis) as"/>
 <result pre="long been used in the treatment of malaria and subsequently," exact="autoimmune" post="disorders (such as rheumatoid arthritis) as well as in"/>
 <result pre="retroviruses, and coronaviruses [86], exhibiting strong antiviral effects on coronavirus" exact="infection" post="of primate cells [72,87]. The drug can be effective"/>
 <result pre="may mitigate the severe inflammatory cascade associated with severe COVID-19" exact="disease" post="[86]. Recently, hydroxychloroquine was found to be more potent"/>
 <result pre="inhibiting SARS-CoV-2 in vitro [91], fortuitous, since it appears that" exact="lower" post="toxicity has been attributed to this derivative [92]. A"/>
 <result pre="work suggesting that combined therapy resulted in rapid reduction in" exact="viral" post="load. Clearly, more robust clinical studies are needed and"/>
 <result pre="studies are needed and have been called for [74]. While" exact="systemic" post="chloroquine and its derivatives appear to be associated with"/>
 <result pre="combination treatment with azithromycin [74]. The well-known association with irreversible" exact="visual" post="loss due to retinal toxicity is considered a late"/>
 <result pre="It transpires that zinc inhibits coronavirus polymerase activity [101], blocking" exact="viral" post="replication. For this reason, combination treatment for Covid-19 with"/>
 <result pre="unsurprising, given the passage of time, that an understanding of" exact="viral" post="oculotropism from the 1918 influenza epidemic has faded. Yet"/>
 <result pre="drugs and issues relating to drug bioavailability, initially in the" exact="upper" post="airways and respiratory system, local, topical therapy offers potential"/>
 <result pre="relating to drug bioavailability, initially in the upper airways and" exact="respiratory" post="system, local, topical therapy offers potential significant advantages. Many"/>
 <result pre="topical therapy offers potential significant advantages. Many of the proposed" exact="systemic" post="therapies such as chloroquine, zinc and ACE inhibitors have"/>
 <result pre="eye drops have apparently been efficacious in the management of" exact="dry eye syndrome" post="in humans [75,76]. Significant side effects were not reported,"/>
 <result pre="have apparently been efficacious in the management of dry eye" exact="syndrome" post="in humans [75,76]. Significant side effects were not reported,"/>
 <result pre="were not reported, however there is a report of chloroquine" exact="keratopathy" post="in workers chronically exposed to chloroquine dust [103]. Chronic"/>
 <result pre="chloroquine keratopathy in workers chronically exposed to chloroquine dust [103]." exact="Chronic" post="usage is unlikely in the setting here proposed. ACE"/>
 <result pre="ACE inhibitors have been used topically in animal models of" exact="glaucoma" post="[104]. In this class of drugs, agents such as"/>
 <result pre="the risk of coronavirus infection. Early reports have suggested that" exact="hypertension" post="may be a risk factor for infection but these"/>
 <result pre="have suggested that hypertension may be a risk factor for" exact="infection" post="but these are unconfirmed [107]. Azithromycin has also previously"/>
 <result pre="in the human eye as a 1â€&quot;1.5% solution to treat" exact="ocular" post="infections [78,79]. In the case of hydroxychloroquine, preliminary calculations"/>
 <result pre="the human eye as a 1â€&quot;1.5% solution to treat ocular" exact="infections" post="[78,79]. In the case of hydroxychloroquine, preliminary calculations suggest"/>
 <result pre="two orders of magnitude higher than plasma levels (reached with" exact="systemic" post="treatment [108]) could be achieved. Conclusion At this point,"/>
 <result pre="combination of chloroquine, zinc and azithromycin to the eyelids and" exact="ocular" post="surface with eye drops or a spray/aerosol. This would"/>
 <result pre="point into the human body, would reduce the risk of" exact="systemic" post="side effects and conserve drugs that may become scarce,"/>
 <result pre="since the dosage required would be much less than for" exact="systemic" post="treatment. A spray or aerosol preparation would also allow"/>
 <result pre="oculotropic, this may be superfluous. If a patient has active" exact="infection" post="of the respiratory tree, then this combined medication could"/>
 <result pre="be superfluous. If a patient has active infection of the" exact="respiratory" post="tree, then this combined medication could also be given"/>
 <result pre="is that ACE2 receptors from the outer cornea, through the" exact="lacrimal" post="drainage system to the respiratory and gastrointestinal systems as"/>
 <result pre="the outer cornea, through the lacrimal drainage system to the" exact="respiratory" post="and gastrointestinal systems as well as both nasal and"/>
 <result pre="to be safe, extensive, convenient and at low cost. The" exact="ocular" post="surface, offering all of the benefits of local treatment"/>
 <result pre="J Med382202076076231978944 2GreenA.Li Wenliang. ObituaryLancet3952020682 3accessedhttps://www.msn.com/en-us/news/world/chinese-doctor-who-issued-early-warning-on-virus-dies/ar-BBZJrw6?ocid=spartandhp 4LuCheng-weiXiu-fenLiuJiaZhi-fang2019-nCoV transmission through the" exact="ocular" post="surface must not be ignoredLancet395102242020e3932035510 5MaxcyK.F.The transmission of infection"/>
 <result pre="the ocular surface must not be ignoredLancet395102242020e3932035510 5MaxcyK.F.The transmission of" exact="infection" post="through the eyeJ Am Med Assoc721919636639 6BelserJ.A.RotaP.A.TumpeyT.M.Ocular tropism of"/>
 <result pre="infection through the eyeJ Am Med Assoc721919636639 6BelserJ.A.RotaP.A.TumpeyT.M.Ocular tropism of" exact="respiratory" post="virusesMicrobiol Mol Biol Rev77201314415623471620 7BelserJ.A.LashR.R.GargS.TumpeyT.M.MainesT.R.The eyes have it: influenza"/>
 <result pre="respiratory virusesMicrobiol Mol Biol Rev77201314415623471620 7BelserJ.A.LashR.R.GargS.TumpeyT.M.MainesT.R.The eyes have it: influenza" exact="virus infection" post="beyond the respiratory tractLancet Infect Dis182018e220e22729477464 8BelserJ.A.DavisC.T.BalishA.EdwardsL.E.ZengH.MainesT.R.GustinK.M.MartÃ­nezI.L.FasceR.CoxN.J.KatzJ.M.TumpeyT.M.Pathogenesis, transmissibility, and"/>
 <result pre="virusesMicrobiol Mol Biol Rev77201314415623471620 7BelserJ.A.LashR.R.GargS.TumpeyT.M.MainesT.R.The eyes have it: influenza virus" exact="infection" post="beyond the respiratory tractLancet Infect Dis182018e220e22729477464 8BelserJ.A.DavisC.T.BalishA.EdwardsL.E.ZengH.MainesT.R.GustinK.M.MartÃ­nezI.L.FasceR.CoxN.J.KatzJ.M.TumpeyT.M.Pathogenesis, transmissibility, and"/>
 <result pre="Rev77201314415623471620 7BelserJ.A.LashR.R.GargS.TumpeyT.M.MainesT.R.The eyes have it: influenza virus infection beyond the" exact="respiratory" post="tractLancet Infect Dis182018e220e22729477464 8BelserJ.A.DavisC.T.BalishA.EdwardsL.E.ZengH.MainesT.R.GustinK.M.MartÃ­nezI.L.FasceR.CoxN.J.KatzJ.M.TumpeyT.M.Pathogenesis, transmissibility, and ocular tropism of"/>
 <result pre="infection beyond the respiratory tractLancet Infect Dis182018e220e22729477464 8BelserJ.A.DavisC.T.BalishA.EdwardsL.E.ZengH.MainesT.R.GustinK.M.MartÃ­nezI.L.FasceR.CoxN.J.KatzJ.M.TumpeyT.M.Pathogenesis, transmissibility, and" exact="ocular" post="tropism of a highly pathogenic avian influenza A (H7N3)"/>
 <result pre="Dis182018e220e22729477464 8BelserJ.A.DavisC.T.BalishA.EdwardsL.E.ZengH.MainesT.R.GustinK.M.MartÃ­nezI.L.FasceR.CoxN.J.KatzJ.M.TumpeyT.M.Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic" exact="avian influenza" post="A (H7N3) virus associated with human conjunctivitisJ Virol8720135746575423487452 9ChandraN.FrÃ¤ngsmyrL.ImhofS.CaraballoR.ElofssonM.ArnbergN.Sialic"/>
 <result pre="human conjunctivitisJ Virol8720135746575423487452 9ChandraN.FrÃ¤ngsmyrL.ImhofS.CaraballoR.ElofssonM.ArnbergN.Sialic acid-containing glycans as cellular receptors for" exact="ocular" post="human adenoviruses: implications for tropism and treatmentViruses1152019395 10Eye hospital"/>
 <result pre="for tropism and treatmentViruses1152019395 10Eye hospital eye. Lancet.21983106510666138606 11Accessedhttps://www.enttoday.org/article/otolaryngologists-may-contract-covid-19-during-surgery/ 12ChuC.M.PoonL.L.ChengV.C.Initial" exact="viral" post="load and the outcomes of SARSCMAJ (Can Med Assoc"/>
 <result pre="lenses: a potential source of nosocomial infections?Eye3220181021102729379104 16OYongK.KillerbyM.PanC.Y.Outbreak of epidemic" exact="keratoconjunctivitis" post="caused by human adenovirus type D53 in an eye"/>
 <result pre="among Iranian ophthalmologists: a preliminary surveyMedGenMed6420041 18QaderU.J.A.The prevalence of adenoviral" exact="conjunctivitis" post="in Tikrit district and the role of traditional medicine"/>
 <result pre="of traditional medicine &quot;OM AL KAASH&quot; in transmission of the" exact="disease" post="and in the severity of complicationsTikrit Medical Journal1720113040 19ChanW.M.LiuD.T.ChanP.K.Precautions"/>
 <result pre="19ChanW.M.LiuD.T.ChanP.K.Precautions in ophthalmic practice in a hospital with a major" exact="acute" post="SARS outbreak: an experience from Hong KongEye20200628328915877099 20LiJ.O.LamD.S.C.ChenY.TingD.S.W.Novel Coronavirus"/>
 <result pre="acute SARS outbreak: an experience from Hong KongEye20200628328915877099 20LiJ.O.LamD.S.C.ChenY.TingD.S.W.Novel Coronavirus" exact="disease" post="2019 (COVID-19): the importance of recognising possible early ocular"/>
 <result pre="Coronavirus disease 2019 (COVID-19): the importance of recognising possible early" exact="ocular" post="manifestation and using protective eyewearBr J Ophthalmol104202029729832086236 21LiQ.GuanX.WuP.Early transmission"/>
 <result pre="Engl J Med38220201199120731995857 22PengX.XuX.LiY.ChengL.ZhouX.RenB.Transmission routes of 2019-nCoV and controls in" exact="dental" post="practiceInt J Oral Sci122020932127517 23WHO | Update 27 -"/>
 <result pre="future Accessed 6 April 2020. 24TellierR.LiY.CowlingB.J.TangJ.W.Recognition of aerosol transmission of" exact="infectious" post="agents: a commentaryBMC Infect Dis19201910130704406 25ZamanM.L.DoughtyM.J.ButtonN.F.The exposed ocular surface"/>
 <result pre="transmission of infectious agents: a commentaryBMC Infect Dis19201910130704406 25ZamanM.L.DoughtyM.J.ButtonN.F.The exposed" exact="ocular" post="surface and its relationship to spontaneous eyeblink rate in"/>
 <result pre="Eye Res6719986816869990332 26SotoyamaM.VillanuevaM.B.G.JonaiH.SaitoS.Ocular surface area as an informative index of" exact="visual" post="ergonomicsInd Health319954356 27EhlersN.On the size of the conjunctival sacActa"/>
 <result pre="Dermatol15520061170117617107385 36TayyariF.MarchantD.MoraesT.J.DuanW.MastrangeloP.HegeleR.G.Identification of nucleolin as a cellular receptor for human" exact="respiratory" post="syncytial virusNat Med1720111132113521841784 37XuX.ChenP.WangJ.Evolution of the novel coronavirus from"/>
 <result pre="2019-nCov. bioRxiv 2020.01.vol. 26.919985; doi: 10.1101/2020.01.26.919985. 39WuK.LiW.PengG.LiF.Crystal structure of NL63" exact="respiratory" post="coronavirus receptor-binding domain complexed with its human receptorProc Natl"/>
 <result pre="A1062009199701997419901337 40LiW.SuiJ.HuangI.C.KuhnJ.H.The S proteins of human coronavirus NL63 and severe" exact="acute" post="respiratory syndrome coronavirus bind overlapping regions of ACE2Virology367200736737417631932 41ZhouP.YangX.WangX.A"/>
 <result pre="40LiW.SuiJ.HuangI.C.KuhnJ.H.The S proteins of human coronavirus NL63 and severe acute" exact="respiratory" post="syndrome coronavirus bind overlapping regions of ACE2Virology367200736737417631932 41ZhouP.YangX.WangX.A pneumonia"/>
 <result pre="S proteins of human coronavirus NL63 and severe acute respiratory" exact="syndrome" post="coronavirus bind overlapping regions of ACE2Virology367200736737417631932 41ZhouP.YangX.WangX.A pneumonia outbreak"/>
 <result pre="acute respiratory syndrome coronavirus bind overlapping regions of ACE2Virology367200736737417631932 41ZhouP.YangX.WangX.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="in understanding SARS pathogenesisJ Pathol203200463163715141377 43JiaH.P.LookD.C.ShiL.ACE2 receptor expression and severe" exact="acute" post="respiratory syndrome coronavirus infection depend on differentiation of human"/>
 <result pre="understanding SARS pathogenesisJ Pathol203200463163715141377 43JiaH.P.LookD.C.ShiL.ACE2 receptor expression and severe acute" exact="respiratory" post="syndrome coronavirus infection depend on differentiation of human airway"/>
 <result pre="SARS pathogenesisJ Pathol203200463163715141377 43JiaH.P.LookD.C.ShiL.ACE2 receptor expression and severe acute respiratory" exact="syndrome" post="coronavirus infection depend on differentiation of human airway epitheliaJ"/>
 <result pre="Pathol203200463163715141377 43JiaH.P.LookD.C.ShiL.ACE2 receptor expression and severe acute respiratory syndrome coronavirus" exact="infection" post="depend on differentiation of human airway epitheliaJ Virol792005146141462116282461 44SavaskanE.LÃ¶fflerK.U.MeierF.MÃ¼ller-SpahnF.FlammerJ.MeyerP.Immunohistochemical"/>
 <result pre="of angiotensin-converting enzyme, angiotensin II and AT1 receptor in human" exact="ocular" post="tissuesOphthalmic Res36200431232015627831 45SungnakW.HuangN.BÃ©cavinC.SARS-CoV-2 entry factors are highly expressed in"/>
 <result pre="tissuesOphthalmic Res36200431232015627831 45SungnakW.HuangN.BÃ©cavinC.SARS-CoV-2 entry factors are highly expressed in nasal" exact="epithelial" post="cells together with innate immune genesNat Med2020 Apr 2310.1038/s41591-020-0868-6Epub"/>
 <result pre="and innate immune responses of the coronavirus SARS-CoV-2 in human" exact="respiratory" post="tract and conjunctiva: an analysis in ex-vivo and in-vitro"/>
 <result pre="2610.1002/jmv.25725[Epub ahead of print] [PMID: 32100876] doi: 58ColavitaF.LapaD.CarlettiF.SARS-CoV-2 isolation from" exact="ocular" post="secretions of a patient with COVID-19 in Italy with"/>
 <result pre="secretions of a patient with COVID-19 in Italy with prolonged" exact="viral" post="RNA detectionAnn Intern Med2020 Apr 17M20M1176 59ChenL.LiuM.ZhangZ.Ocular manifestations of"/>
 <result pre="J Ophthalmol2020 Apr 710.1136/bjophthalmol-2020-316304bjophthalmol-2020-316304 60PaulsenF.Functional anatomy and immunological interactions of" exact="ocular" post="surface and adnexaDev Ophthalmol412008213518453759 61ChentoufiA.A.DasguptaG.NesburnA.B.Nasolacrimal duct closure modulates ocular"/>
 <result pre="of ocular surface and adnexaDev Ophthalmol412008213518453759 61ChentoufiA.A.DasguptaG.NesburnA.B.Nasolacrimal duct closure modulates" exact="ocular" post="mucosal and systemic CD4(+) T-cell responses induced following topical"/>
 <result pre="and adnexaDev Ophthalmol412008213518453759 61ChentoufiA.A.DasguptaG.NesburnA.B.Nasolacrimal duct closure modulates ocular mucosal and" exact="systemic" post="CD4(+) T-cell responses induced following topical ocular or intranasal"/>
 <result pre="ocular mucosal and systemic CD4(+) T-cell responses induced following topical" exact="ocular" post="or intranasal immunizationClin Vaccine Immunol17201034235320089796 62ChanW.M.YuenK.S.FanD.S.LamD.S.ChanP.K.SungJ.J.Tears and conjunctival scrapings"/>
 <result pre="safety of the angiotensin receptor blockers in the management of" exact="hypertension" post="and other cardiovascular diseasesDrug Saf382015335425416320 68NateshR.SchwagerS.L.SturrockE.D.AcharyaK.R.Crystal structure of the"/>
 <result pre="angiotensin receptor blockers in the management of hypertension and other" exact="cardiovascular" post="diseasesDrug Saf382015335425416320 68NateshR.SchwagerS.L.SturrockE.D.AcharyaK.R.Crystal structure of the human angiotensin-converting enzyme-lisinopril"/>
 <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell cultureAntimicrob Agents Chemother5820144875488424841269 72WangM.CaoR.ZhangL.Remdesivir"/>
 <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother5820144875488424841269 72WangM.CaoR.ZhangL.Remdesivir and"/>
 <result pre="of azithromycin ophthalmic 1% solution (AzaSite(Â®)) for the treatment of" exact="ocular" post="infectionsOphthalmol Eye Dis4201211423650453 79AmzaA.GoldschmidtP.EinterzE.Elimination of active trachoma after two"/>
 <result pre="the treatment of ocular infectionsOphthalmol Eye Dis4201211423650453 79AmzaA.GoldschmidtP.EinterzE.Elimination of active" exact="trachoma" post="after two topical mass treatments with azithromycin 1.5% eye"/>
 <result pre="damage than help fight COVID-19Microb Infect202020S1286S457930071-X 86SavarinoA.BoelaertJ.R.CassoneA.MajoriG.CaudaR.Effects of chloroquine on" exact="viral" post="infections: an old drug against today's diseases?Lancet Infect Dis3200372272714592603"/>
 <result pre="Infect Dis3200372272714592603 87VincentM.J.BergeronE.BenjannetS.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J220056916115318 88KeyaertsE.VijgenL.MaesP.NeytsJ.Van RanstM.In vitro inhibition of severe"/>
 <result pre="infection and spreadVirol J220056916115318 88KeyaertsE.VijgenL.MaesP.NeytsJ.Van RanstM.In vitro inhibition of severe" exact="acute" post="respiratory syndrome coronavirus by chloroquineBiochem Biophys Res Commun323200426426815351731 89SavarinoA.Di"/>
 <result pre="and spreadVirol J220056916115318 88KeyaertsE.VijgenL.MaesP.NeytsJ.Van RanstM.In vitro inhibition of severe acute" exact="respiratory" post="syndrome coronavirus by chloroquineBiochem Biophys Res Commun323200426426815351731 89SavarinoA.Di TraniL.DonatelliI.CaudaR.CassoneA.New"/>
 <result pre="spreadVirol J220056916115318 88KeyaertsE.VijgenL.MaesP.NeytsJ.Van RanstM.In vitro inhibition of severe acute respiratory" exact="syndrome" post="coronavirus by chloroquineBiochem Biophys Res Commun323200426426815351731 89SavarinoA.Di TraniL.DonatelliI.CaudaR.CassoneA.New insights"/>
 <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020ciaa23710.1093/cid/ciaa237 92LiuJ.CaoR.XuM.Hydroxychloroquine, a"/>
 <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020ciaa23710.1093/cid/ciaa237 92LiuJ.CaoR.XuM.Hydroxychloroquine, a less"/>
 <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2)Clin Infect Dis2020ciaa23710.1093/cid/ciaa237 92LiuJ.CaoR.XuM.Hydroxychloroquine, a less toxic"/>
 <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="in vitroCell Discovery62020161932194981 93GautretP.LagierJ.C.ParolaP.Clinical and microbiological effect of a"/>
 <result pre="98HednerT.SamulessonO.WÃ¤hrborgP.WadenvikH.UngK.A.EkbomA.Nabumetone: therapeutic use and safety profile in the management of" exact="osteoarthritis" post="and rheumatoid arthritisDrugs64200423152343; discussion 2344-515456329 99Giocanti-AurÃ©ganA.CouturierA.GirmensJ.F.Le MerY.MassambaN.BarreauE.AudoI.collab: DHU Vision"/>
 <result pre="Ophtalmol41201836336729678344 100XueJ.MoyerA.PengB.WuJ.HannafonB.N.DingW.Q.Chloroquine is a zinc ionophorePloS One92014e109180 101KaushikN.SubramaniC.AnangS.Zinc salts block" exact="hepatitis E" post="virus replication by inhibiting the activity of viral RNA-dependent"/>
 <result pre="block hepatitis E virus replication by inhibiting the activity of" exact="viral" post="RNA-dependent RNA polymeraseJ Virol912017e00754-17 102ShittuM.O.AfolamiO.I.Improving the efficacy of Chloroquine"/>
 <result pre="synergy for future COVID-19 clinical trialsInf Med282020192197Ahead of print 103EriksenL.S.Chloroquine" exact="keratopathy" post="in chloroquine workers after topical dust exponation. A case"/>
 <result pre="workers after topical dust exponation. A case reportActa Ophthalmol571979823825525306 104WatkinsR.W.BaumT.CedenoK.Topical" exact="ocular" post="hypotensive effects of the novel angiotensin converting enzyme inhibitor"/>
 <result pre="receptor antagonistsBlood Pres Suppl12001611 106IshiyamaY.GallagherP.E.AverillD.B.TallantE.A.BrosnihanK.B.FerrarioC.M.Upregulation of angiotensin-converting enzyme 2 after" exact="myocardial infarction" post="by blockade of angiotensin II receptorsHypertension43200497097615007027 107LeungC.Clinical features of"/>
 <result pre="Pharmacol2719897717792757893 109XuH.ZhongL.DengJ.PengJ.DanH.ZengX.LiT.ChenQ.High expression of ACE2 receptor of 2019-nCoV on the" exact="epithelial" post="cells of oral mucosaInt J Oral Sci1212020832094336"/>
</results>
